Bretazenil or Ro16-6028 is an anxiolytic drug of the benzodiazepine class and is an imidazopyrrolobenzodiazepine highly potent GABA receptor antagonist. It acts as a partial agonist with minimal side effects, is a partial agonist and binds to the α1, α2, α3, α4, α5 and α6 subunits of the GABA receptor.
Bretazenil produces a sedative-hypnotic effect, 0.5 mg of bretazenil is equivalent to 10 mg of diazepam.
Bretazenil has less potential for abuse and is used in the treatment of epilepsy, insomnia, anxiety.
Bretazenil is a designer benzodiazepine drug and its toxicological and pharmacological properties are under investigation and not fully understood. This chemical is intended for research and identification of properties, in special rooms, on special laboratory equipment, in compliance with all safety measures.
You can get acquainted with the prices and buy Bretazenil online right now, at OmniCompound company. We provide all the necessary information about the products and provide a quality guarantee.
| CAS | 84379-13-5 |
| Product Name | Bretazenil, Ro16-6028 |
| Molecular Formula | C19H20BrN3O3 |
| Molecular Weight | 418.291 g·mol−1 |
| IUPAC Name | tert-butyl-8-bromo-11,12,13,13a-tetrahydro-9-oxo-9H-imidazo(1,5-a)-pyrrolo(2,1-c)(1,4)benzodiazepine-1-carboxylate |
| InChI | InChI=1S/C19H20BrN3O3/c1-19(2,3)26-18(25)15-16-13-8-5-9-22(13)17(24)14-11(20)6-4-7-12(14)23(16)10-21-15/h4,6-7,10,13H,5,8-9H2,1-3H3/t13-/m0/s1 |
| Solubility |
|
| Synonyms | Bretazenil, Ro16-6028 |
| Purity | ≥98% |
| Formulation | A solid, Powder |
| Storage | -20°C |
| Stability | ≥ 2 years |
Quick Inquiry
